Alexandr Myasnikov

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 254 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

Francisco Cervantes, David M. Ross, Atanas Radinoff et al. · Leukemia · 2021 · 66 citations · Full text

Medicine, Hematology, Pharmacology +9

Interferon gamma in the treatment of patients with moderate COVID-19

Alexandr Myasnikov, P. A. Talyzin, Ershov Fi · Problems of Virology · 2021 · 33 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study

Moshe Mittelman, Sarit Assouline, Evangelos Briasoulis et al. · Blood · 2012 · 11 citations

Medicine, Hematology, Pharmacotherapy +16